Charles River Laboratories International, Inc. Earnings Dividend

Charles River Laboratories International, Inc.’s revenue fell -2.72% since last year same period to $1004.08Mn in the Q2 2026. On a quarterly growth basis, Charles River Laboratories International, Inc. has generated 0.83% jump in its revenue since last 3-months.

Charles River Laboratories International, Inc.’s net profit fell -102.83% since last year same period to $-1.48Mn in the Q2 2026. On a quarterly growth basis, Charles River Laboratories International, Inc. has generated 90.02% jump in its net profits since last 3-months.

Charles River Laboratories International, Inc.’s net profit margin fell -102.91% since last year same period to -0.15% in the Q2 2026. On a quarterly growth basis, Charles River Laboratories International, Inc. has generated 90.1% jump in its net profit margins since last 3-months.

Charles River Laboratories International, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.72 - a 39.49% jump from last quarter’s estimates.

Charles River Laboratories International, Inc.’s earning per share (EPS) estimates for the current year stand at 2.72.

Charles River Laboratories International, Inc.’s earning per share (EPS) fell -3.21% since last year same period to 3.02 in the Q2 2026. This indicates that the Charles River Laboratories International, Inc. has generated -3.21% annual rate of fall in its earning per share (EPS) in the last 4 quarters.